## **Core Concept**
The question tests knowledge of drug interactions with oral contraceptive pills (OCPs), specifically those that can reduce the efficacy of OCPs, leading to contraceptive failure. The underlying principle involves the induction of hepatic enzymes that metabolize the contraceptive hormones.

## **Why the Correct Answer is Right**
The correct answer, **B. Rifampicin**, is right because rifampicin is a potent inducer of the cytochrome P450 enzyme system in the liver. This induction increases the metabolism of the estrogen and progesterone components of oral contraceptive pills. As a result, the plasma concentrations of these hormones decrease, which can lead to reduced contraceptive efficacy and potentially result in contraceptive failure, as seen in the scenario.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a drug name, making it impossible to assess its correctness.
- **Option C:** This option is also blank and does not provide a drug name, making it impossible to assess its correctness.
- **Option D:** Similarly, this option does not provide a drug name and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that several drugs can induce the cytochrome P450 system and potentially decrease the effectiveness of oral contraceptives. These include not just rifampicin but also other antibiotics, antiepileptics (like phenytoin, carbamazepine), and certain antifungals. Clinically, it's essential to advise patients on potential drug interactions and consider alternative contraceptive methods when prescribing such drugs.

## **Correct Answer: B. Rifampicin**